Comprehensive analysis of 19q12 amplicon in human gastric cancers

Modern Pathology

Volumn 19, Issue 6, 2006, Pages 854-863

  Suet, Yi Leung ^a   Ho, Coral ^b   Tu, I Ping ^c   Li, Rui ^d   So, Samuel ^d   Chu, Kent Man ^a   Siu, Tsan Yuen ^a   Chen, Xin ^b  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c INSTITUTE OF STATISTICAL SCIENCE   (Taiwan)

^d STANFORD UNIVERSITY   (United States)

Author keywords

Amplification; Array CGH; Gastric cancer; Microarrays

Indexed keywords

COMPLEMENTARY DNA; CYCLIN E; CYCLIN E1; GENOMIC DNA; UNCLASSIFIED DRUG;

AMPLICON; ARTICLE; CANCER CELL; CARCINOGENESIS; CELL CYCLE REGULATION; CELL PROLIFERATION; CHROMOSOME 19Q; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME NUMBER; COMPARATIVE GENOMIC HYBRIDIZATION; COMPARATIVE STUDY; COMPUTER PROGRAM; CORRELATION ANALYSIS; DATA BASE; DNA MICROARRAY; ENHANCER REGION; GENE AMPLIFICATION; GENE CLUSTER; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; IN VIVO STUDY; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROMOTER REGION; REAL TIME POLYMERASE CHAIN REACTION; SAMPLE; STATISTICAL ANALYSIS; STOMACH CANCER; TUMOR;

ADENOCARCINOMA; CHROMOSOMES, HUMAN, PAIR 19; CYCLIN E; DNA, NEOPLASM; GENE AMPLIFICATION; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; ONCOGENE PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; STOMACH NEOPLASMS;

EID: 33646869235     PISSN: 08933952     EISSN: 15300285     Source Type: Journal    
DOI: 10.1038/modpathol.3800593     Document Type: Article

References (46)

1. Lengauer C, Kinzler KW, Vogelstein B. Genetic instabilities in human cancers. Nature 1998;396:643-649.
2. Schraml P, Bucher C, Bissig H, et al. Cyclin E overexpression and amplification in human tumours. J Pathol 2003;200:375-382.
3. Tsuda H, Bandera CA, Birrer MJ, et al. Cyclin E amplification and overexpression in clear cell adenocarcinoma of the ovary. Oncology 2004;67:291-299.
4. Richter J, Wagner U, Kononen J, et al. High-throughput tissue microarray analysis of cyclin E gene amplification and overexpression in urinary bladder cancer. Am J Pathol 2000;157:787-794.
5. Cassia R, Moreno-Bueno G, Rodriguez-Perales S, et al. Cyclin E gene (CCNE) amplification and hCDC4 mutations in endometrial carcinoma. J Pathol 2003;201:589-595.
6. Koff A, Giordano A, Desai D, et al. Formation and activation of a cyclin E-cdk2 complex during the G1 phase of the human cell cycle. Science 1992;257:1689-1694.
7. Zariwala M, Liu J, Xiong Y. Cyclin E2, a novel human G1 cyclin and activating partner of CDK2 and CDK3, is induced by viral oncoproteins. Oncogene 1998;17:2787-2798.
8. Akli S, Keyomarsi K. Cyclin E and its low molecular weight forms in human cancer and as targets for cancer therapy. Cancer Biol Ther 2003;2:S38-S47.
9. Keyomarsi K, Tucker SL, Buchholz TA, et al. Cyclin E and survival in patients with breast cancer. N Engl J Med 2002;347:1566-1575.
10. Al-Aynati MM, Radulovich N, Ho J, et al. Overexpression of G1-S cyclins and cyclin-dependent kinases during multistage human pancreatic duct cell carcinogenesis. Clin Cancer Res 2004;10:6598-6605.
11. Sutter T, Dansranjavin T, Lubinski J, et al. Overexpression of cyclin E protein is closely related to the mutator phenotype of colorectal carcinoma. Int J Colorectal Dis 2002;17:374-380.
12. Parkin DM, Pisani P, Ferlay J. Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 1999;80:827-841.
13. Parsonnet J, Friedman GD, Vandersteen DP, et al. Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med 1991;325:1127-1131.
14. Sakakura C, Mori T, Sakabe T, et al. Gains, losses, and amplifications of genomic materials in primary gastric cancers analyzed by comparative genomic hybridization. Genes Chromosomes Cancer 1999;24:299-305.
15. Koo SH, Kwon KC, Shin SY, et al. Genetic alterations of gastric cancer: comparative genomic hybridization and fluorescence in situ hybridization studies. Cancer Genet Cytogenet 2000;117:97-103.
16. Wu MS, Chang MC, Huang SP, et al. Correlation of histologic subtypes and replication error phenotype with comparative genomic hybridization in gastric cancer. Genes Chromosomes Cancer 2001;30:80-86.
17. Kim YH, Kim NG, Lim JG, et al. Chromosomal alterations in paired gastric adenomas and carcinomas. Am J Pathol 2001;158:655-662.
18. Weiss MM, Kuipers EJ, Postma C, et al. Genomic profiling of gastric cancer predicts lymph node status and survival. Oncogene 2003;22:1872-1879.
19. Akama Y, Yasui W, Yokozaki H, et al. Frequent amplification of the cyclin E gene in human gastric carcinomas. Jpn J Cancer Res 1995;86:617-621.
20. Ahn MJ, Kim BH, Jang SJ, et al. Expression of cyclin D1 and cyclin E in human gastric carcinoma and its clinicopathologic significance. J Korean Med Sci 1998;13:513-518.
21. Hofler H, Becker KF. Molecular mechanisms of carcinogenesis in gastric cancer. Recent Results Cancer Res 2003;162:65-72.
22. So JB, Samarasinge K, Raju GC. Expression of cell-cycle regulators p27 and cyclin E correlates with survival in gastric carcinoma patients. J Surg Res 2000;94:56-60.
23. Chetty R, Sitti CW. Cyclin E immunoexpression in gastric cancer does not correlate with clinicopathological parameters. Histopathology 2003;42:66-69.
24. Leung SY, Chen X, Chu KM, et al. Phospholipase A2 group IIA expression in gastric adenocarcinoma is associated with prolonged survival and less frequent metastasis. Proc Natl Acad Sci USA 2002;99:16203-16208.
25. Chen X, Leung SY, Yuen ST, et al. Variation in gene expression patterns in human gastric cancers. Mol Biol Cell 2003;14:3208-3215.
26. Patil MA, Gutgemann I, Zhang J, et al. Array-based comparative genomic hybridization reveals recurrent chromosomal aberrations and Jab1 as a potential target for 8q gain in hepatocellular carcinoma. Carcinogenesis 2005;26:2050-2057.
27. Jain AN, Tokuyasu TA, Snijders AM, et al. Fully automatic quantification of microarray image data. Genome Res 2002;12:325-332.
28. Ginzinger DG, Godfrey TE, Nigro J, et al. Measurement of DNA copy number at microsatellite loci using quantitative PCR analysis. Cancer Res 2000;60:5405-5409.
29. Whitney AR, Diehn M, Popper SJ, et al. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci USA 2003;100:1896-1901.
30. Tusher VG, Tibshirani R, Chu G. Significance analysis of microarrays applied to the ionizing radiation response. Proc Natl Acad Sci USA 2001;98:5116-5121.
31. Boyle EI, Weng S, Gollub J, et al. GO::TermFinder - open source software for accessing gene ontology information and finding significantly enriched gene ontology terms associated with a list of genes. Bioinformatics 2004;20:3710-3715.
32. Whitfield ML, Sherlock G, Saldanha AJ, et al. Identification of genes periodically expressed in the human cell cycle and their expression in tumors. Mol Biol Cell 2002;13:1977-2000.
33. Chung CH, Bernard PS, Perou CM. Molecular portraits and the family tree of cancer. Nat Genet 2002;32(Suppl):533-540.
34. Holloway AJ, van Laar RK, Tothill RW, et al. Options available - from start to finish - for obtaining data from DNA microarrays II. Nat Genet 2002;32(Suppl):481-489.
35. Crawley JJ, Furge KA. Identification of frequent cytogenetic aberrations in hepatocellular carcinoma using gene-expression microarray data. Genome Biol 2002;3:RESEARCH0075.
36. Husing J, Zeschnigk M, Boes T, et al. Combining DNA expression with positional information to detect functional silencing of chromosomal regions. Bioinformatics 2003;19:2335-2342.
37. van Eijk R, Oosting J, Sieben N, et al. Visualization of regional gene expression biases by microarray data sorting. Biotechniques 2004;36:592-594, 596.
38. Harding MA, Arden KC, Gildea JW, et al. Functional genomic comparison of lineage-related human bladder cancer cell lines with differing tumorigenic and metastatic potentials by spectral karyotyping, comparative genomic hybridization, and a novel method of positional expression profiling. Cancer Res 2002;62:6981-6989.
39. Pollack JR, Sorlie T, Perou CM, et al. Microarray analysis reveals a major direct role of DNA copy number alteration in the transcriptional program of human breast tumors. Proc Natl Acad Sci USA 2002;99:12963-12968.
40. Furge KA, Dykema KJ, Ho C, et al. Comparison of array-based comparative genomic hybridization with gene expression-based regional expression biases to identify genetic abnormalities in hepatocellular carcinoma. BMC Genomics 2005;6:67.
41. Van Leuven F, Torrekens S, Moechars D, et al. Molecular cloning of a gene on chromosome 19q12 coding for a novel intracellular protein: analysis of expression in human and mouse tissues and in human tumor cells, particularly Reed-Sternberg cells in Hodgkin disease. Genomics 1998;54:511-520.
42. Wei W, Gu JX, Zhu CQ, et al. Interaction with general transcription factor IIF (TFIIF) is required for the suppression of activated transcription by RPB5-mediating protein (RMP). Cell Res 2003;13:111-120.
43. Dorjsuren D, Lin Y, Wei W, et al. RMP, a novel RNA polymerase II subunit 5-interacting protein, counteracts transactivation by hepatitis B virus X protein. Mol Cell Biol 1998;18:7546-7555.
44. Pennacchio LA, Bergmann A, Fukushima A, et al. Structure, sequence and location of the UQCRFS1 gene for the human Rieske Fe-S protein. Gene 1995;155:207-211.
45. Ohashi Y, Kaneko SJ, Cupples TE, et al. Ubiquinol cytochrome c reductase (UQCRFS1) gene amplification in primary breast cancer core biopsy samples. Gynecol Oncol 2004;93:54-58.
46. Kaneko SJ, Gerasimova T, Smith ST, et al. CA125 and UQCRFS1 FISH studies of ovarian carcinoma. Gynecol Oncol 2003;90:29-36.